T13	C1579433 22 31	insulines
#13	AnnotatorNotes T13	"C1579433", "Insulin [EPC]", "Pharmacologic Substance" ,"CHEM"
T14	C0021641 22 31	insulines
#14	AnnotatorNotes T14	"C0021641", "Insulin", "Amino Acid Peptide or Protein|Pharmacologic Substance|Hormone" ,"CHEM"
T15	C0030705 170 178	patients
#15	AnnotatorNotes T15	"C0030705", "Patients", "Patient or Disabled Group" ,"LIVB"
T16	C0030705 196 204	patients
#16	AnnotatorNotes T16	"C0030705", "Patients", "Patient or Disabled Group" ,"LIVB"
T17	C0537270 122 138	insuline détémir
#17	AnnotatorNotes T17	"C0537270", "insulin detemir", "Amino Acid Peptide or Protein|Pharmacologic Substance|Hormone" ,"CHEM"
T18	C0001792 179 183	âgés
#18	AnnotatorNotes T18	"C0001792", "Elderly (population group)", "Population Group" ,"LIVB"
T19	C1999167 179 183	âgés
#19	AnnotatorNotes T19	"C1999167", "Old age", "Finding" ,"DISO"
T20	C0202048 69 88	contrôle glycémique
#20	AnnotatorNotes T20	"C0202048", "Glucose measurement by monitoring device", "Laboratory Procedure" ,"PROC"
T22	C0237401 148 160	individuelle
#22	AnnotatorNotes T22	"C0237401", "Individual", "Human" ,"LIVB"
T23	C0027361 148 160	individuelle
#23	AnnotatorNotes T23	"C0027361", "Persons", "Population Group" ,"LIVB"
T24	C0948807 205 225;236 246	atteints de troubles hépatiques
#24	AnnotatorNotes T24	"C0948807", "Hepatic impairment", "Disease or Syndrome" ,"DISO"
T25	C0341697 205 232	atteints de troubles rénaux
#25	AnnotatorNotes T25	"C0341697", "Renal impairment", "Disease or Syndrome" ,"DISO"
